Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Psoriasis (Immunology) - Drugs In Development, 2021
US$ 2,500.00
Psoriasis (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Drugs In Development, 2021, provides an over...
July 2021
1178 pages
Radiation Toxicity - Drugs In Development, 2021
US$ 2,000.00
Radiation Toxicity - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Toxicity (Radiation Sickness, Acute Radiation Synd...
July 2021
337 pages
Rectal Cancer (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Rectal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Drugs In Development, 2021, provides a...
July 2021
417 pages
Rhabdomyosarcoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Rhabdomyosarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rhabdomyosarcoma - Drugs In Development, 2021, prov...
July 2021
662 pages
Rosacea (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Rosacea (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rosacea - Drugs In Development, 2021, provides an overvie...
July 2021
107 pages
Synovial Sarcoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Synovial Sarcoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Synovial Sarcoma - Drugs In Development, 2021, prov...
July 2021
539 pages
Tetanus (Infectious Disease) - Drugs In Development, 2021
US$ 2,000.00
Tetanus (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tetanus - Drugs In Development, 2021, provides an...
July 2021
98 pages
Thalassemia (Hematology) - Drugs In Development, 2021
US$ 2,000.00
Thalassemia (Hematology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Drugs In Development, 2021, provides an...
July 2021
278 pages
Thyroid Cancer (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Thyroid Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thyroid Cancer - Drugs In Development, 2021, provides...
July 2021
1423 pages
Type 2 Angiotensin II Receptor - Drugs In Development, 2021
US$ 3,500.00
Type 2 Angiotensin II Receptor - Drugs In Development, 2021 SUMMARY According to the recently published report 'Type 2 Angiotensin II Receptor - Drugs In Development, 2021'; Type 2 Angiotensin II Rece...
July 2021
57 pages
Uveal Melanoma (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Uveal Melanoma (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveal Melanoma - Drugs In Development, 2021, provides...
July 2021
545 pages
Uveitis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Uveitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uveitis - Drugs In Development, 2021, provides an overv...
July 2021
288 pages
Vitiligo (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Vitiligo (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vitiligo - Drugs In Development, 2021, provides an overv...
July 2021
203 pages
5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021
US$ 3,500.00
5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021'; 5-Hydroxytryptamine Recept...
June 2021
85 pages
Apoptosis Regulator BAX - Drugs In Development, 2021
US$ 3,500.00
Apoptosis Regulator BAX - Drugs In Development, 2021 SUMMARY Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) - Apoptosis regulator BAX or bcl-2-like protein 4 is a protein is encoded b...
June 2021
46 pages
Arrhythmias (Cardiovascular) - Drugs In Development, 2021
US$ 2,000.00
Arrhythmias (Cardiovascular) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arrhythmias (Cardiovascular) - Drugs In Developmen...
June 2021
92 pages
Aryl Hydrocarbon Receptor - Drugs In Development, 2021
US$ 3,500.00
Aryl Hydrocarbon Receptor - Drugs In Development, 2021 SUMMARY According to the recently published report 'Aryl Hydrocarbon Receptor - Drugs In Development, 2021'; Aryl Hydrocarbon Receptor (Class E B...
June 2021
139 pages
Burns (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Burns (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burns (Dermatology) - Drugs In Development, 2021, provides...
June 2021
142 pages
